Salim Haffar, PCI Pharma CEO

PCI fur­ther ex­pands in­to New Eng­land with fill-fin­ish up­grade in New Hamp­shire

A Philadel­phia-based CD­MO will drop $100 mil­lion in­to its asep­tic liq­uid fill-fin­ish and ster­ile lyophiliza­tion tech­nol­o­gy at its re­cent­ly-ac­quired Bed­ford, NH cam­pus.

PCI Phar­ma bought the Lyophiliza­tion Ser­vices of that New Eng­land site at the end of 2021. The new ex­pan­sion will add a 50,000 square-foot fa­cil­i­ty that fea­tures a fill-fin­ish line with a ful­ly iso­lat­ed con­tain­ment sys­tem. It will have the ca­pac­i­ty to fill 400 vials per minute, which will help PCI up its speed and get ther­a­pies to pa­tients quick­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.